Indication
Anemia due to bleeding uterine leiomyoma
Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium. Read more about Anemia due to bleeding uterine leiomyoma
3 drugs 1 manufacturers
Drugs that treat it
Common Anemia due to bleeding uterine leiomyoma therapies.
LUPRON DEPOT (LUPANETA) (leuprolide acetate)
LUPRON DEPOT (LUPANETA) (leuprolide acetate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAnemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium.
Primarily affecting individuals of reproductive age, particularly perimenopausal females, the condition is driven by leiomyomas (especially submucosal or large intramural subtypes) that alter uterine vascularity, disrupt normal hemostatic myometrial contractility, and expand the endometrial surface area.
This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocrit, microcytosis, hypochromia, and clinical manifestations such as pallor, fatigue, dyspnea, and tachycardia.
- nih.gov
Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocrit, microcytosis, hypochromia, and clinical manifestations suc...
- nih.gov
Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium
- nih.gov
Anemia due to bleeding uterine leiomyoma is a secondary hematologic complication arising from excessive, abnormal uterine bleeding—most frequently heavy or prolonged menstrual bleeding—caused by benign smooth muscle neoplasms of the myometrium Primarily affecting individuals of reproductive age, particularly perimenopausal females, the condition is driven by leiomyomas (especially submucosal or large intramural subtypes) that alter uterine vascularity, disrupt normal hemostatic myometrial contra...
- sacmd.com
Primarily affecting individuals of reproductive age, particularly perimenopausal females, the condition is driven by leiomyomas (especially submucosal or large intramural subtypes) that alter uterine vascularity, disrupt normal hemostatic myometrial contractility, and expand the endometrial surface area This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocri...
- trueprecisionmedical.com
Primarily affecting individuals of reproductive age, particularly perimenopausal females, the condition is driven by leiomyomas (especially submucosal or large intramural subtypes) that alter uterine vascularity, disrupt normal hemostatic myometrial contractility, and expand the endometrial surface area This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocri...
- innovativegyn.com
This chronic or acute blood loss depletes systemic iron stores faster than erythropoiesis can compensate, culminating in iron-deficiency anemia characterized by decreased hemoglobin and hematocrit, microcytosis, hypochromia, and clinical manifestations such as pallor, fatigue, dyspnea, and tachycardia
Personalize your experience
Follow Anemia due to bleeding uterine leiomyoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.